Showing results (1171-1180 of 6,326) with videos related to
Sort By:
Pageof 633
Diabetes, Obesity & Metabolism|January 2, 2025
The predictive value of estimated glucose disposal rate and its association with myocardial infarction, heart failure, atrial fibrillation and ischemic strokeHao Huang, Yan Xiong, Jie Zhou, et al.Diabetes, Obesity & Metabolism|January 9, 2025
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trialAmanda Siriwardana, Luke Buizen, Min Jun, et al.Diabetes, Obesity & Metabolism|January 8, 2025
A preliminary randomized trial of a brief dissonance-based type 2 diabetes prevention programme for adults with pre-diabetesEric Stice, Paul Rohde, Christopher D Desjardins, et al.Diabetes, Obesity & Metabolism|March 7, 2025
Impact of healthy lifestyles on the risk of metabolic dysfunction-associated steatotic liver disease among adults with comorbid hypertension and diabetes: Novel insight from a largely middle-aged and elderly cohort in South ChinaJun-Yan Xi, Yi-Jing Wang, Xiao-Heng Li, et al.Diabetes, Obesity & Metabolism|January 20, 2025
Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff modelPhil McEwan, Volker Foos, Geraint Roberts, et al.Diabetes, Obesity & Metabolism|January 17, 2025
Prognostic value of changes in vibration-controlled transient elastography parameters for liver, cardiovascular and mortality outcomes in individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: The Rio de Janeiro type 2 diabetes cohortNathalie C Leite, Cristiane A Villela-Nogueira, Lorrane V Santos, et al.Diabetes, Obesity & Metabolism|December 5, 2024
The fibrosis investigating navigator in diabetes (FIND): A tool to predict liver fibrosis risk in subjects with diabetesMingkai Li, Hongsheng Yu, Sizhe Wan, et al.Diabetes, Obesity & Metabolism|December 2, 2024
The role of the glucagon-FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibitionMaria Moreno-Lopez, Isaline Louvet, Nathalie Delalleau, et al.Diabetes, Obesity & Metabolism|March 3, 2025
The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesityIskandar Idris, Oluwaseun AnyiamDiabetes, Obesity & Metabolism|March 6, 2025
Data-driven discovery of midlife cardiometabolic profile associated with incident early-onset and late-onset dementiaJiang Li, Jie Li, Yuefeng Yu, et al.Pageof 633